You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDR001

Showing 26 - 50 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Worldwide (LAG525, PDR001)

Completed
Has Results
  • Advanced Solid Tumors
  • New York, New York
  • +23 more
Jan 17, 2022

Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

Recruiting
  • Carcinoma, Renal Cell
  • New York, New York
    Columbia University Medical Center
May 6, 2022

MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • (no location specified)
Aug 5, 2022

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Stage III NSCLC Trial in Seoul (standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001,

Withdrawn
  • Stage III NSCLC
  • standard platinum-based concurrent chemoradiotherapy, followed by consolidation with PDR001
  • PDR001 concurrent with standard platinum-based chemoradiation, followed by consolidation with PDR001
  • Seoul, Korea, Republic of
    Department of Oncology, Yonsei University College of Medicine
Oct 14, 2020

Triple-negative Breast Cancer Trial in Worldwide (LAG525, Spartalizumab, Carboplatin)

Completed
Has Results
  • Triple-negative Breast Cancer
  • Chandler, Arizona
  • +32 more
Jan 27, 2023

Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

Recruiting
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jun 13, 2022

Metastatic Colorectal Cancer Trial in Worldwide (spartalizumab (PDR001), regorafenib)

Completed
  • Metastatic Colorectal Cancer
  • St Leonards, New South Wales, Australia
  • +10 more
Dec 9, 2020

Solid Tumors, Lymphomas Trial in Worldwide (GWN323, PDR001)

Completed
  • Solid Tumors
  • Lymphomas
  • Chicago, Illinois
  • +8 more
Feb 18, 2021

Hepatocellular Carcinoma Trial in Worldwide (PDR001, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Detroit, Michigan
  • +8 more
Dec 16, 2020

NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Fayetteville, Arkansas
  • +7 more
Jan 21, 2022

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,

Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin,

Completed
Has Results
  • Well-differentiated Non-functional NET of Thoracic Origin
  • +3 more
  • PDR001
  • Duarte, California
  • +34 more
Mar 16, 2021

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

BRAF V600 Colorectal Cancer Trial in Worldwide (Dabrafenib, LTT462, Trametinib)

Recruiting
  • BRAF V600 Colorectal Cancer
  • Los Angeles, California
  • +17 more
Jun 7, 2022

Advanced Solid Tumors Trial in Worldwide (PDR001)

Recruiting
  • Advanced Solid Tumors
  • PDR001
  • New York, New York
  • +42 more
Jan 23, 2023

Melanoma, Non Small Cell Lung Cancer Trial (PDR001, Panobinostat)

Withdrawn
  • Melanoma
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 1, 2019

Hepatocellular Carcinoma (HCC), Solid Malignancies Trial in Worldwide (FGF401, PDR001)

Completed
Has Results
  • Hepatocellular Carcinoma (HCC)
  • Solid Malignancies
  • Los Angeles, California
  • +26 more
Nov 21, 2020

Gastric Cancer Trial in Seoul (MCS110/PDR001 combination)

Unknown status
  • Gastric Cancer
  • MCS110/PDR001 combination
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 8, 2019

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,

Active, not recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Cancer, Lung Cancer Metastatic, Immunotherapy Trial in Seoul (PDR001)

Unknown status
  • Cancer
  • +2 more
  • PDR001
  • Seoul, Korea, Republic of
    Asan Medical Center
Oct 1, 2018

Advanced Malignancies Trial in Nagoya, Kashiwa, Kobe-city (PDR001)

Completed
  • Advanced Malignancies
  • PDR001
  • Nagoya, Aichi, Japan
  • +2 more
Jun 6, 2018